Figures computed from official regulatory filings — .
Ownershipinsiders 0% · institutions 26.77%
In USD · as of Oct 5, 2026
Ask the machine
Search and compare insider transactions, companies and their statistics in plain language. Your question becomes a query over available data, not a conversation or investment advice.
Data for abrdn Life Sciences Investors only. No web search. Global per-insider statistics are excluded.
An executed search uses one credit, even with no results. Errors and unsupported questions use no credits.
Abrdn Life Sciences Investors is a closed-ended equity mutual fund launched and managed by abrdn Inc. The fund invests in public equity markets across the globe. It seeks to invest in stocks of companies operating in the life sciences sector, including the biotechnology, pharmaceutical, diagnostics, managed healthcare, medical equipment, hospitals, healthcare information technology and services, devices and supplies industries, and in agriculture and environmental management industries. The fund primarily invests in growth stocks of small cap companies. It employs fundamental analysis with a focus on factors such as market position for services or products, experience of business management, technological expertise, and the ability either to generate funds internally to finance growth or to secure outside sources of capital to create its portfolio. The fund benchmarks the performance of its portfolio against the NASDAQ Biotech Index and the S&P 500 Index. Abrdn Life Sciences Investors was formed on February 20, 1992 and is domiciled in the United States.
Market information source · Oct 5, 2026
Periods recorded in the consulted sources. These do not certify the legal dates of name changes.
SEC company identity · Oct 5, 2026
Open-market timeline · full history
69 buys40 sells— close pricebar = usd volume, √ scaleclick a period to filter the table
| Insider | Type | Value · USD | Signals | Details |
|---|---|---|---|---|
| Mahai Chris LaVictoire | Buy | $10.5K | conv 61First in 12mo |
| SEC |
| Pittard Christian | Buy | $133.7K | conv 50First in 12mo | SEC |
| Saba Capital Management, L.P.track record | Sell | $98.5K | SEC |
| Saba Capital Management, L.P.track record | Sell | $588.5K | Unusual size | SEC |
| Saba Capital Management, L.P.track record | Sell | $565.7K | SEC |
| Saba Capital Management, L.P.track record | Sell | $340.3K | SEC |
| Saba Capital Management, L.P.track record | Sell | $28.3K | SEC |
| Saba Capital Management, L.P.track record | Sell | $9.9K | SEC |
| Saba Capital Management, L.P.track record | Sell | $215.9K | SEC |
| Weinstein Boaztrack record | Sell | $197.7K | SEC |
| Weinstein Boaztrack record | Sell | $329.5K | SEC |
| Saba Capital Management, L.P.track record | Sell | $5.5K | SEC |
| Saba Capital Management, L.P.track record | Sell | $150.7K | SEC |
| Weinstein Boaztrack record | Sell | $145.1K | SEC |
| Weinstein Boaztrack record | Sell | $286.6K | SEC |
| Saba Capital Management, L.P.track record | Sell | $7.2K | SEC |
| Saba Capital Management, L.P.track record | Sell | $9K | SEC |
| Saba Capital Management, L.P.track record | Sell | $152K | SEC |
| Saba Capital Management, L.P.track record | Sell | $16.7K | SEC |
| Weinstein Boaztrack record | Sell | $107.7K | SEC |
| Weinstein Boaztrack record | Sell | $20.3K | SEC |
| Saba Capital Management, L.P.track record | Sell | $179.7K | SEC |
| Saba Capital Management, L.P.track record | Sell | $335.9K | SEC |
| Weinstein Boaztrack record | Sell | $126.2K | SEC |
| Weinstein Boaztrack record | Sell | $79.7K | SEC |